NCT06872905View on ClinicalTrials.gov

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

RecruitingOBSERVATIONAL
Enrollment

158

Participants

Timeline

Start Date

May 30, 2025

Primary Completion Date

August 16, 2027

Study Completion Date

August 16, 2027

Conditions
Aortoiliac Occlusive Disease
Interventions
DEVICE

GORE VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX)

Treatment of Target Lesions with the VBX Device in the aortic and common iliac positions during the CERAB procedure.

Trial Locations (8)

10029

RECRUITING

Mount Sinai Medical Center, New York

14203

RECRUITING

Research Foundation SUNY Buffalo, Buffalo

24016

RECRUITING

Carilion Clinic, Roanoke

35131

NOT_YET_RECRUITING

Azienda Ospedaliero-Universitaria di Padova, Padua

43210

RECRUITING

Ohio State University Medical Center, Columbus

54449

RECRUITING

Marshfield Hospital, Marshfield

93721

NOT_YET_RECRUITING

University of California, Fresno

08103

RECRUITING

Cooper University Hospital, Camden

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY

NCT06872905 - Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease | Biotech Hunter | Biotech Hunter